Closed-blood Sampling Devices in the Adult Critically Ill Patient
Effectiveness of Closed-blood Sampling Devices in the Adult Critically Ill Patient: Multicenter Randomized Clinical Trial
University of Barcelona
216 participants
Nov 11, 2024
INTERVENTIONAL
Conditions
Summary
Based on the hypothesis that the strategy of using Closed-Blood Sampling Devices (CSBD, experimental group) compared to the usual practice (waste discard volume, control group), in critically ill adult patients, will decrease the amount of blood withdrawn for laboratory tests, we want to analyze the number of red blood cells (RBC) administered and arterial catheter-related adverse events (catheter-related bacteremia, catheter obstruction, CBSD malfunction, loss of arterial pressure waveform on the patient's bedside monitor) in both study groups, during ICU stay and up to a maximum of 21 days.
Eligibility
Inclusion Criteria1
- Adult patients with an arterial catheter who agree to participate in the study, with a stay in the ICU of 24h and a minimum of 72h more with an arterial catheter
Exclusion Criteria6
- Patients with chronic renal failure
- Patients with active gastrointestinal bleeding
- Patients diagnosed with hematologic cancer
- Women with menstruation at the time of admission
- Pregnant women
- Withdrawal criteria: presence of active gastrointestinal bleeding during the study inclusion period.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
blood collection with Closed-Blood Sampling System (CBSD)
Blood collection without CBSD, usual practice, need to waste discard volume
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06478160